Analysis of somatic mutations in braf, CDKN2A/p16 and PI3KCA in patients with medullary thyroid carcinoma

By                    

Molecular Medicine Reports, Vol. 13, Iss. 2, 2016-01 ,pp. : 1653-1660

Spandidos Publications

Access to resources Recommend Favorite

Contribution of CDKN2A/P16 INK4A , P14 ARF , CDK4 and BRCA1/2 germline mutations in individuals with suspected genetic predisposition to uveal melanoma

By Buecher B.  

Familial Cancer, Vol. 9, Iss. 4, 2010-12 ,pp. : 663-667

Springer Publishing Company

Access to resources Recommend Favorite

Frequent Deletion and Methylation in SH3GL2 and CDKN2A Loci are Associated with Early- and Late-onset Breast Carcinoma

By Sinha Satyabrata  

Annals of Surgical Oncology, Vol. 15, Iss. 4, 2008-04 ,pp. : 1070-1080

Springer Publishing Company

Access to resources Recommend Favorite

Promoter methylation of DAPK1, FHIT, MGMT, and CDKN2A genes in cervical carcinoma

By Banzai Chiaki   Nishino Koji   Quan Jinhua   Yoshihara Kosuke   Sekine Masayuki   Yahata Tetsuro   Tanaka Kenichi  

International Journal of Clinical Oncology, Vol. 19, Iss. 1, 2014-02 ,pp. : 127-132

Springer Publishing Company

Access to resources Recommend Favorite

Associations of 9p21 variants with cutaneous malignant melanoma, nevi, and pigmentation phenotypes in melanoma-prone families with and without CDKN2A mutations

By Yang Xiaohong   Liang Xueying   Pfeiffer Ruth   Wheeler William   Maeder Dennis   Burdette Laurie   Yeager Meredith   Chanock Stephen   Tucker Margaret   Goldstein Alisa  

Familial Cancer, Vol. 9, Iss. 4, 2010-12 ,pp. : 625-633

Springer Publishing Company

Access to resources Recommend Favorite